Correlation Between Salesforce and Shenzhen Bioeasy
Specify exactly 2 symbols:
By analyzing existing cross correlation between Salesforce and Shenzhen Bioeasy Biotechnology, you can compare the effects of market volatilities on Salesforce and Shenzhen Bioeasy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Shenzhen Bioeasy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Shenzhen Bioeasy.
Diversification Opportunities for Salesforce and Shenzhen Bioeasy
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Salesforce and Shenzhen is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Shenzhen Bioeasy Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Bioeasy Bio and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Shenzhen Bioeasy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Bioeasy Bio has no effect on the direction of Salesforce i.e., Salesforce and Shenzhen Bioeasy go up and down completely randomly.
Pair Corralation between Salesforce and Shenzhen Bioeasy
Considering the 90-day investment horizon Salesforce is expected to generate 1.25 times less return on investment than Shenzhen Bioeasy. But when comparing it to its historical volatility, Salesforce is 2.56 times less risky than Shenzhen Bioeasy. It trades about 0.35 of its potential returns per unit of risk. Shenzhen Bioeasy Biotechnology is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 888.00 in Shenzhen Bioeasy Biotechnology on August 28, 2024 and sell it today you would earn a total of 167.00 from holding Shenzhen Bioeasy Biotechnology or generate 18.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Shenzhen Bioeasy Biotechnology
Performance |
| Timeline |
| Salesforce |
| Shenzhen Bioeasy Bio |
Salesforce and Shenzhen Bioeasy Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Shenzhen Bioeasy
The main advantage of trading using opposite Salesforce and Shenzhen Bioeasy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Shenzhen Bioeasy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Bioeasy will offset losses from the drop in Shenzhen Bioeasy's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Shenzhen Bioeasy vs. Industrial and Commercial | Shenzhen Bioeasy vs. China Construction Bank | Shenzhen Bioeasy vs. Agricultural Bank of | Shenzhen Bioeasy vs. Bank of China |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |